BioCentury | Jan 11, 2010
Company News

Affomix, KalGene deal

...Affomix will use its Y2HExpress technology to generate antibodies against undisclosed targets from Kalgene for potential...
...and is eligible for milestones. Further terms were not disclosed. Affomix Corp. , Branford, Conn. KalGene Pharmaceuticals Inc....
Items per page:
1 - 1 of 1
BioCentury | Jan 11, 2010
Company News

Affomix, KalGene deal

...Affomix will use its Y2HExpress technology to generate antibodies against undisclosed targets from Kalgene for potential...
...and is eligible for milestones. Further terms were not disclosed. Affomix Corp. , Branford, Conn. KalGene Pharmaceuticals Inc....
Items per page:
1 - 1 of 1